Sirona met with Investors and Brokers at Canaccord in Vancouver on September 15th, 2015.
This is the most recent corporate presentation that was put together for this recent Investor Event. You will find current collaborations, what they have in the pipeline, and the revenue growth potential.
Sirona’s presentation also reveals why management is so excited about its next major transaction.
Sirona Biochem Corp. is a biotechnology company with an innovative platform of fluorination chemistry technology. This platform is used to develop safer, more effective cosmetic and pharmaceutical active ingredients, which are licensed to partners in exchange for upfront, milestone and royalty payments. Sirona’s pipeline has produced licensing deals with Valeant Pharmaceuticals and Fosun Pharma.